Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

8
(from Reference Citation Analysis)

Article PDFs (2)

Cited by > 0 (8)

Searched Name

J E Hawley

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Schmidt AL, Labaki C, Hsu CY, Bakouny Z, Balanchivadze N, Berg SA, Blau S, Daher A, El Zarif T, Friese CR, Griffiths EA, Hawley JE, Hayes-Lattin B, Karivedu V, Latif T, Mavromatis BH, McKay RR, Nagaraj G, Nguyen RH, Panagiotou OA, Portuguese AJ, Puc M, Santos Dutra M, Schroeder BA, Thakkar A, Wulff-Burchfield EM, Mishra S, Farmakiotis D, Shyr Y, Warner JL, Choueiri TK. COVID-19 vaccination and breakthrough infections in patients with cancer. Ann Oncol 2022;33:340-346. [PMID: 34958894 PMCID: PMC8704021 DOI: 10.1016/j.annonc.2021.12.006] [Citation(s) in RCA: 57] [Impact Index Per Article: 28.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2021] [Revised: 12/14/2021] [Accepted: 12/16/2021] [Indexed: 12/12/2022] Open

Affiliation(s)

A L Schmidt Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
C Labaki Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
C-Y Hsu Department of Biostatistics, Vanderbilt University, Nashville, USA
Z Bakouny Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
N Balanchivadze Hematology and Oncology Fellowship Program, Henry Ford Cancer Institute, Detroit, USA
S A Berg Department of Internal Medicine and Cancer Biology, Division of Hematology and Oncology, Cardinal Bernardin Cancer Centre, Loyola University Chicago, Maywood, USA
S Blau Division of Oncology, Northwest Medical Specialties, Tacoma, USA; Division of Hematology, University of Washington, Seattle, USA
A Daher Hartford HealthCare Medical Group, Hartford, USA
T El Zarif Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
C R Friese University of Michigan School of Nursing, School of Public Health, and Rogel Cancer Centre, Ann Arbor, USA
E A Griffiths Leukemia Section, Roswell Park Comprehensive Cancer Centre, Buffalo, USA
J E Hawley Herbert Irving Comprehensive Cancer Centre, Columbia University Irving Medical Centre, New York, USA; University of Washington/Fred Hutchinson Cancer Research Center, Seattle, USA
B Hayes-Lattin Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, USA
V Karivedu Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Centre, Columbus, USA
T Latif Division of Hematology/Medical Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, USA
B H Mavromatis Department of Cancer, Oncology, Hematology, UPMC Western Maryland, Cumberland, USA
R R McKay Department of Medicine, Division of Hematology/Oncology, University of California San Diego, San Diego, USA
G Nagaraj Division of Medical Oncology & Hematology, Department of Medicine, Loma Linda University Cancer Centre, Loma Linda, USA
R H Nguyen Department of Medicine, Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, USA
O A Panagiotou Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, USA
A J Portuguese Division of Hematology, University of Washington, Seattle, USA
M Puc Department of Surgery, Section of Thoracic Surgery, Virtua Health, Marlton, USA
M Santos Dutra Segal Cancer Centre of the Jewish General Hospital, Montréal, Canada
B A Schroeder Virginia Mason Cancer Institute, Seattle, USA
A Thakkar Division of Oncology, Montefiore Medical Centre, Bronx, USA
E M Wulff-Burchfield Department of Medicine, Divisions of Medical Oncology and Palliative Medicine, The University of Kansas Health System, Westwood, USA
S Mishra Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA
D Farmakiotis Department of Medicine, Division of Infectious Diseases, The Warren Alpert Medical School of Brown University, Providence, USA
Yu Shyr Department of Biostatistics, Vanderbilt University, Nashville, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA
J L Warner Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, USA; Department of Medicine, Division of Hematology/Oncology, Vanderbilt University, Nashville, USA; Department of Biomedical Informatics, Vanderbilt University, Nashville, USA.
T K Choueiri Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.

Collapse

Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol 2021;32:787-800. [PMID: 33746047 PMCID: PMC7972830 DOI: 10.1016/j.annonc.2021.02.024] [Citation(s) in RCA: 202] [Impact Index Per Article: 67.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Revised: 02/18/2021] [Accepted: 02/28/2021] [Indexed: 12/17/2022] Open

Abstract

BACKGROUND

Patients with cancer may be at high risk of adverse outcomes from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies.

PATIENTS AND METHODS

Patients with active or historical cancer and a laboratory-confirmed SARS-CoV-2 diagnosis recorded between 17 March and 18 November 2020 were included. The primary outcome was COVID-19 severity measured on an ordinal scale (uncomplicated, hospitalized, admitted to intensive care unit, mechanically ventilated, died within 30 days). Multivariable regression models included demographics, cancer status, anticancer therapy and timing, COVID-19-directed therapies, and laboratory measurements (among hospitalized patients).

RESULTS

A total of 4966 patients were included (median age 66 years, 51% female, 50% non-Hispanic white); 2872 (58%) were hospitalized and 695 (14%) died; 61% had cancer that was present, diagnosed, or treated within the year prior to COVID-19 diagnosis. Older age, male sex, obesity, cardiovascular and pulmonary comorbidities, renal disease, diabetes mellitus, non-Hispanic black race, Hispanic ethnicity, worse Eastern Cooperative Oncology Group performance status, recent cytotoxic chemotherapy, and hematologic malignancy were associated with higher COVID-19 severity. Among hospitalized patients, low or high absolute lymphocyte count; high absolute neutrophil count; low platelet count; abnormal creatinine; troponin; lactate dehydrogenase; and C-reactive protein were associated with higher COVID-19 severity. Patients diagnosed early in the COVID-19 pandemic (January-April 2020) had worse outcomes than those diagnosed later. Specific anticancer therapies (e.g. R-CHOP, platinum combined with etoposide, and DNA methyltransferase inhibitors) were associated with high 30-day all-cause mortality.

CONCLUSIONS

Clinical factors (e.g. older age, hematological malignancy, recent chemotherapy) and laboratory measurements were associated with poor outcomes among patients with cancer and COVID-19. Although further studies are needed, caution may be required in utilizing particular anticancer therapies.

CLINICAL TRIAL IDENTIFIER

NCT04354701.

Collapse

Affiliation(s)

P Grivas University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA.
A R Khaki University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA; Stanford University, Stanford, USA
T M Wise-Draper University of Cincinnati Cancer Center, Cincinnati, USA
B French Vanderbilt University Medical Center, Nashville, USA
C Hennessy Vanderbilt University Medical Center, Nashville, USA
C-Y Hsu Vanderbilt University Medical Center, Nashville, USA
Y Shyr Vanderbilt University Medical Center, Nashville, USA
X Li Vanderbilt University School of Medicine, Nashville, USA
T K Choueiri Dana-Farber Cancer Institute, Boston, USA
C A Painter Broad Institute, Cancer Program, Cambridge, USA
S Peters Lausanne University, Lausanne, Switzerland
B I Rini Vanderbilt University Medical Center, Nashville, USA
M A Thompson Advocate Aurora Health, Milwaukee, USA
S Mishra Vanderbilt University Medical Center, Nashville, USA
D R Rivera Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, USA
J D Acoba University of Hawaii Cancer Center, Honolulu, USA
M Z Abidi University of Colorado School of Medicine, Aurora, USA
Z Bakouny Dana-Farber Cancer Institute, Boston, USA
B Bashir Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA
T Bekaii-Saab Mayo Clinic Cancer Center, Phoenix, USA
S Berg Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, USA
E H Bernicker Houston Methodist Cancer Center, Houston, USA
M A Bilen Winship Cancer Institute of Emory University, Atlanta, USA
P Bindal Beth Israel Deaconess Medical Center, Boston, USA
R Bishnoi University of Florida, Gainesville, USA
N Bouganim McGill University Health Centre, Montréal, Canada
D W Bowles University of Colorado School of Medicine, Aurora, USA
A Cabal University of California San Diego, Moores Cancer Center, La Jolla, USA
P F Caimi University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA
D D Chism Thompson Cancer Survival Center, Knoxville, USA
J Crowell St. Elizabeth Healthcare, Edgewood, USA
C Curran Dana-Farber Cancer Institute, Boston, USA
A Desai Mayo Clinic Cancer Center, Rochester, USA
B Dixon St. Elizabeth Healthcare, Edgewood, USA
D B Doroshow Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA
E B Durbin Markey Cancer Center, University of Kentucky, Lexington, USA
A Elkrief McGill University Health Centre, Montréal, Canada
D Farmakiotis The Warren Alpert Medical School of Brown University, Providence, USA
A Fazio Tufts Medical Center Cancer Center, Boston and Stoneham, USA
L A Fecher University of Michigan Rogel Cancer Center, Ann Arbor, USA
D B Flora St. Elizabeth Healthcare, Edgewood, USA
C R Friese University of Michigan Rogel Cancer Center, Ann Arbor, USA
J Fu Tufts Medical Center Cancer Center, Boston and Stoneham, USA
S M Gadgeel Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA
M D Galsky Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA
D M Gill Intermountain Healthcare, Salt Lake City, USA
M J Glover Stanford University, Stanford, USA
S Goyal George Washington University, Washington DC, USA
P Grover University of Cincinnati Cancer Center, Cincinnati, USA
S Gulati University of Cincinnati Cancer Center, Cincinnati, USA
S Gupta Cleveland Clinic Taussig Cancer Institute, Cleveland, USA
S Halabi Duke University, Durham, USA
T R Halfdanarson Mayo Clinic Cancer Center, Rochester, USA
B Halmos Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA
D J Hausrath Vanderbilt University School of Medicine, Nashville, USA
J E Hawley Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA
E Hsu Hartford HealthCare, Hartford, USA; University of Connecticut, Farmington, USA
M Huynh-Le George Washington University, Washington DC, USA
C Hwang Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA
C Jani Mount Auburn Hospital, Cambridge, USA
A Jayaraj Hartford HealthCare, Hartford, USA
D B Johnson Vanderbilt University Medical Center, Nashville, USA
A Kasi University of Kansas Medical Center, Kansas City, USA
H Khan The Warren Alpert Medical School of Brown University, Providence, USA
V S Koshkin University of California, San Francisco, San Francisco, USA
N M Kuderer Advanced Cancer Research Group, LLC, Kirkland, USA
D H Kwon University of California, San Francisco, San Francisco, USA
P E Lammers Baptist Cancer Center, Memphis, USA
A Li Baylor College of Medicine, Houston, USA
A Loaiza-Bonilla Cancer Treatment Centers of America, Philadelphia, USA
C A Low Intermountain Healthcare, Salt Lake City, USA
M B Lustberg The Ohio State University, Columbus, USA
G H Lyman University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA
R R McKay University of California San Diego, Moores Cancer Center, La Jolla, USA
C McNair Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA
H Menon Penn State Health/Penn State Cancer Institute/St. Joseph Cancer Center, Hershey, USA
R A Mesa Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA
V Mico Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, USA
D Mundt Advocate Aurora Health, Milwaukee, USA
G Nagaraj Loma Linda University Cancer Center, Loma Linda, USA
E S Nakasone University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA
J Nakayama Case Western Reserve University, Cleveland, USA; University Hospitals Cleveland Medical Center, Cleveland, USA
A Nizam Cleveland Clinic Taussig Cancer Institute, Cleveland, USA
N L Nock University Hospitals Seidman Cancer Center, Cleveland, USA; Case Western Reserve University, Cleveland, USA
C Park University of Cincinnati Cancer Center, Cincinnati, USA
J M Patel Beth Israel Deaconess Medical Center, Boston, USA
K G Patel University of California Davis Comprehensive Cancer Center, Sacramento, USA
P Peddi Willis-Knighton Cancer Center, Shreveport, USA
N A Pennell Cleveland Clinic Taussig Cancer Institute, Cleveland, USA
A J Piper-Vallillo Beth Israel Deaconess Medical Center, Boston, USA
M Puc Virtua Health, Marlton, USA
D Ravindranathan Winship Cancer Institute of Emory University, Atlanta, USA
M E Reeves Loma Linda University Cancer Center, Loma Linda, USA
D Y Reuben Medical University of South Carolina, Charleston, USA
L Rosenstein Gunderson Health System, La Crosse, USA
R P Rosovsky Massachusetts General Hospital, Harvard Medical School, Boston, USA
S M Rubinstein University of North Carolina, Chapel Hill, USA
M Salazar Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA
A L Schmidt Dana-Farber Cancer Institute, Boston, USA
G K Schwartz Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, USA
M R Shah Rutgers Cancer Institute of New Jersey, New Brunswick, USA
S A Shah Stanford University, Stanford, USA
C Shah University of Florida, Gainesville, USA
J A Shaya University of California San Diego, Moores Cancer Center, La Jolla, USA
S R K Singh Henry Ford Cancer Institute/Henry Ford Health System, Detroit, USA
M Smits ThedaCare Regional Cancer Center, Appleton, USA
K E Stockerl-Goldstein Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
D G Stover The Ohio State University, Columbus, USA
M Streckfuss Advocate Aurora Health, Milwaukee, USA
S Subbiah Stanley S. Scott Cancer Center, LSU Health Sciences Center, New Orleans, USA
L Tachiki University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, USA
E Tadesse Advocate Aurora Health, Milwaukee, USA
A Thakkar Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA
M D Tucker Vanderbilt University Medical Center, Nashville, USA
A K Verma Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, USA
D C Vinh McGill University Health Centre, Montréal, Canada
M Weiss ThedaCare Regional Cancer Center, Appleton, USA
J T Wu Stanford University, Stanford, USA
E Wulff-Burchfield Mount Auburn Hospital, Cambridge, USA
Z Xie Mayo Clinic Cancer Center, Rochester, USA
P P Yu Hartford HealthCare, Hartford, USA
T Zhang Duke University, Durham, USA
A Y Zhou Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA
H Zhu Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
L Zubiri Massachusetts General Hospital, Harvard Medical School, Boston, USA
D P Shah Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, USA
J L Warner Vanderbilt University Medical Center, Nashville, USA
GdL Lopes University of Miami/Sylvester Comprehensive Cancer Center, Miami, USA

Collapse

Delfino JJ, Hawley JE, Bauszek WW. A Quality Assurance Program for Water Quality Monitoring Studies. ACTA ACUST UNITED AC 2009. [DOI: 10.1080/00139307409437400] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]

Hawley JE, Ingle JD. Improvements in the non-flame atomic fluorescence determination of mercury. Anal Chim Acta 1975;77:71-8. [PMID: 1138578 DOI: 10.1016/s0003-2670(01)95157-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]

Hawley JE, Ingle JD. Improvements in cold vapor atomic absorption determination of mercury. Anal Chem 1975;47:719-23. [PMID: 1137145 DOI: 10.1021/ac60354a010] [Citation(s) in RCA: 32] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]

Russell RD, Farquhar RM, Hawley JE. Isotopic analyses of leads from Broken Hill, Australia with spectrographic analyses. ACTA ACUST UNITED AC 1957. [DOI: 10.1029/tr038i004p00557] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]

Melvin EH, Hawley JE. Spectrochemical determination of iron and copper in commercial oils. J AM OIL CHEM SOC 1951. [DOI: 10.1007/bf02589709] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Evans CD, Schwab AW, Moser HA, Hawley JE, Melvin EH. The flavor problem of soybean oil. VII. Effect of trace metals. J AM OIL CHEM SOC 1951. [DOI: 10.1007/bf02612095] [Citation(s) in RCA: 45] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]